GHK-Cu is one of the most fascinating compounds in current peptide research. This naturally occurring copper peptide tripeptide has attracted significant scientific attention due to its remarkable biological activity across multiple research domains, from skin biology and wound healing models to neurological and anti-inflammatory research.
What Is GHK-Cu?
GHK-Cu stands for Glycyl-L-histidyl-L-lysine copper complex. It is a naturally occurring tripeptide — just three amino acids — that was first identified in human plasma in 1973 by Loren Pickart. The peptide has a strong affinity for copper ions, forming a stable complex that gives it its characteristic blue colour in powder form.
GHK-Cu is found naturally in human plasma, saliva and urine, with plasma concentrations declining significantly with age — from approximately 200 nanograms per millilitre at age 20 to around 80 nanograms per millilitre by age 60. This age related decline has made it a subject of particular research interest in longevity and regenerative biology.
Synthesis and Physical Properties
As a tripeptide GHK-Cu is one of the simplest research peptides to synthesise via Solid Phase Peptide Synthesis. Its short chain length means synthesis yields are exceptionally high and purity levels of 99%+ are routinely achievable.
In its pure form GHK-Cu presents as a distinctive blue powder — the colour resulting from the coordinated copper ions. This makes it immediately visually identifiable, which is useful for quality verification purposes. The molecular weight is approximately 340 Da for the free tripeptide, rising to around 404 Da when complexed with copper.
Areas of Scientific Investigation
GHK-Cu has been studied across a remarkably wide range of biological systems given its simple three amino acid structure.
Skin biology research represents the most extensive area of GHK-Cu literature. Studies have examined its effects on fibroblast activity, collagen synthesis models, and extracellular matrix remodelling in laboratory settings. Research has also investigated its interaction with matrix metalloproteinase systems that regulate tissue remodelling.
Wound healing research has examined GHK-Cu extensively in both in vitro and animal models. Studies have looked at its effects on keratinocyte migration, angiogenesis and inflammatory mediator modulation in wound healing contexts.
Neurological research has investigated GHK-Cu in models examining nerve growth factor activity and neuronal protection, with several studies suggesting interaction with BDNF pathways.
Gene expression research has produced some of the most interesting GHK-Cu literature. Studies by Pickart and colleagues identified that GHK-Cu appears to modulate the expression of a significant number of human genes, including genes associated with inflammation, tissue remodelling and metabolic function.
Anti-inflammatory research has examined GHK-Cu across multiple models, with studies consistently suggesting significant modulation of inflammatory signalling pathways.
GHK-Cu Stability and Storage
GHK-Cu demonstrates good stability in its lyophilised copper complex form. The coordinated copper provides structural stability that simple peptides without metal complexation often lack.
Lyophilised GHK-Cu powder should be stored at 2-8°C for short term use and -20°C for long term storage. Protection from light is important as copper containing compounds can be sensitive to photodegradation. Once reconstituted the solution should be refrigerated and used within an appropriate timeframe.
Reconstitution for Laboratory Use
GHK-Cu reconstitutes readily in bacteriostatic water, producing a characteristic blue solution. The intensity of the blue colour provides a useful visual confirmation of the copper complex integrity, though formal purity verification via HPLC remains essential for research grade applications.
Standard reconstitution practice involves adding bacteriostatic water slowly to the lyophilised powder, allowing it to dissolve without mechanical agitation. The resulting solution should present as a clear to slightly blue coloured liquid.
Verifying GHK-Cu Quality
Quality verification for GHK-Cu should confirm both the peptide purity and the copper complexation. A comprehensive Certificate of Analysis should include HPLC purity data confirming minimum 99% peptide purity, mass spectrometry confirmation of the molecular weight at approximately 404 Da for the copper complex, and visual confirmation of the characteristic blue colour indicating intact copper complexation.
At Pureline Biolabs our GHK-Cu is independently tested by Janoshik Analytical with a minimum specification of 99% purity. Every vial carries a unique QR code linking to the live publicly accessible certificate for that specific batch.
Legal Status in the UK
GHK-Cu is not a licensed medicine in the United Kingdom. It is widely used as an ingredient in cosmetic formulations where it does not require MHRA licensing. For laboratory research purposes it is legally available for purchase and possession. Pureline Biolabs supplies GHK-Cu exclusively for in vitro laboratory research purposes.
Important Disclaimer
All products supplied by Pureline Biolabs Ltd are intended solely for in vitro laboratory research purposes. They are not medicines, not approved for human or veterinary use, and not for human consumption. Researchers are responsible for ensuring compliance with all applicable regulations in their jurisdiction.